NEW YORK, Oct. 8 - Celera Genomics' online database business will become profitable by the end of June 2002, Chief Business Officer Peter Barrett told an investor conference here on Monday.

He added that Celera’s acquisition of Axys Pharmaceuticals, announced in June 2001, is expected to close during the current quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.